It's tough to tell because the third shot of an mRNA could not only do what we absolutely know it does, is it dramatically increased the level of protection. But from an immunological standpoint, it could very well increase the durability of protection by things that you can't readily measure by the level of antibodies that you might have a maturation of the immune system that would prolong the durability.

Anthony Fauci

We are the problem. We have seen the enemy, and it is us. by Anthony Fauci

We are the problem. We have seen the enemy, and it is us.

It means we do have now what looks like treatments for a disease which, not too long ago, we really had no therapeutic approach at all.

What this means is that we do now have what look like (two) treatments for a disease for which not long ago we really had no approach at all.

If you miss a dose or two it is unlikely that there is going to b... by Anthony Fauci

If you miss a dose or two it is unlikely that there is going to be a gap in protection.

I consider it an irony that you have one of the most contagious viruses known to man juxtaposed against one of the most effective vaccines they have, yet we don't do and have not done what could be done - namely eliminate eradicate the virus.

I'd rather be on the single pill a day with very little toxicities than risk something as draconian as a transplant.

The security issue is really having a major negative impact on the ability to respond in an appropriate way, in the classic way that you respond to an Ebola outbreak, to be able to essentially get to the point where you diminish it, diminish it, diminish it, and then it's gone.

The problem is that more than half of the new infections that are coming into the Ebola treatment units are individuals who have no connection to any contact. So we don't know where or how they got infected.

So the good news is that we have a tool we didn't have in the West African outbreak. The sobering news is that we're not able to implement it as extensively as we want to because we don't have access to all the contacts of the contacts of the contacts, because new cases are coming in that we can't trace to any known case.

We'll know probably by the end of 2020, the beginning of 2021, whether or not we do have a successful universal flu vaccine.

One of the most important things about flu that we all have learned through experience is that it is generally unpredictable, that's the nature of flu.

Influenza is really a unique virus, so different from diseases like measles and polio that stay essentially stable, and you just got to vaccinate once or get infected, and essentially, you're good for life. That's not the case with flu. It's very complicated with flu.

Even though flu seasons are unpredictable, not always but often, we can get a hint of what we're going to face from what people in Australia and the southern hemispheres have faced in their winter, which is essentially our summer.

We're watching very closely to see if there's any suggestion of a... by Anthony Fauci

We're watching very closely to see if there's any suggestion of any increasing trend in pertussis.

We haven't even done the phase 1 yet. by Anthony Fauci

We haven't even done the phase 1 yet.

It has the effect of a vaccine. by Anthony Fauci

It has the effect of a vaccine.

Someone who is probably a rural worker in the woods, in the forest, in the jungle gets bit by a mosquito who is infected with yellow fever but likely got it from a monkey, so it goes from animal to human, but it doesn't get into the population of Aedes aegypti, which are very frequent in the big cities like Rio de Janeiro.

He will probably do it on a prorated basis across the Institutes. by Anthony Fauci

He will probably do it on a prorated basis across the Institutes.

We still need about $196 million more. by Anthony Fauci

We still need about $196 million more.

The regular appropriations process takes too long, i don’t want to wait to have to develop a vaccine.